Rosuvastatin calcium 5 mg
Pro Research Analysisby 
Searched over 200M research papers
Rosuvastatin Calcium 5 mg: Efficacy, Safety, and Pharmacokinetics
Introduction to Rosuvastatin Calcium
Rosuvastatin calcium is a widely used statin medication for lowering cholesterol levels and managing hyperlipidemia. It is available in various dosages, including 5 mg, 10 mg, 20 mg, and 40 mg. This article focuses on the 5 mg dosage, examining its efficacy, safety, and pharmacokinetic properties.
Efficacy of Rosuvastatin Calcium 5 mg
Lipid-Lowering Effects
Rosuvastatin calcium 5 mg has been shown to significantly reduce low-density lipoprotein cholesterol (LDL-C) levels in patients with primary hypercholesterolemia. In a controlled clinical trial, patients treated with 5 mg of rosuvastatin calcium experienced a substantial decrease in LDL-C levels, comparable to those treated with 10 mg of atorvastatin calcium. Additionally, in elderly patients with cerebral ischemic stroke, the 5 mg dose effectively improved blood lipid levels, including reductions in total cholesterol (TC), LDL-C, and triglycerides (TG), while increasing high-density lipoprotein cholesterol (HDL-C).
Comparison with Higher Doses
While higher doses of rosuvastatin (10 mg and 20 mg) may offer more pronounced lipid-lowering effects, the 5 mg dose still provides significant benefits. For instance, in elderly patients with coronary heart disease (CHD) and hyperlipidemia, the 5 mg dose resulted in notable reductions in TC, TG, and LDL-C levels, although the 20 mg dose was superior in overall efficacy .
Safety and Tolerability
General Safety Profile
Rosuvastatin calcium 5 mg is generally well-tolerated with a good safety profile. Clinical trials have demonstrated that the 5 mg dose has a safety and tolerability profile similar to that of higher doses, with no significant increase in adverse effects . In elderly patients with CHD and hyperlipidemia, the 5 mg dose was associated with a low incidence of adverse reactions, comparable to higher doses.
Specific Populations
In studies involving elderly patients and those with cerebral ischemic stroke, the 5 mg dose was effective and safe, with no significant adverse effects reported . This makes it a suitable option for patients who may be more susceptible to side effects from higher doses.
Pharmacokinetics of Rosuvastatin Calcium 5 mg
Absorption and Metabolism
The pharmacokinetics of rosuvastatin calcium 5 mg have been extensively studied. In healthy Chinese volunteers, the 5 mg dose exhibited linear pharmacokinetics, with dose-proportional increases in maximum plasma concentration (Cmax) and area under the curve (AUC) . The drug showed minimal accumulation with repeated administration, indicating a stable pharmacokinetic profile.
Genetic Variability
Genetic polymorphisms, particularly in the ABCB1 and ABCG2 genes, can influence the pharmacokinetics of rosuvastatin. Variants in these genes have been associated with higher plasma concentrations of the drug, potentially affecting its efficacy and safety. However, these genetic factors did not significantly alter the pharmacokinetics of the 5 mg dose in the studied populations.
Conclusion
Rosuvastatin calcium 5 mg is an effective and safe option for lowering cholesterol levels in various patient populations, including those with primary hypercholesterolemia, cerebral ischemic stroke, and CHD with hyperlipidemia. Its pharmacokinetic profile is stable and predictable, making it a reliable choice for managing hyperlipidemia. While higher doses may offer greater lipid-lowering effects, the 5 mg dose provides significant benefits with a favorable safety profile.
Sources and full results
Most relevant research papers on this topic